| CATALOG ID NO. | FINOR-MBI-001 |
| STRUCTURE |  |
| IUPAC NAME | 1,3-Dihydro-2H-benzimidazole-2-thione |
| CAS NO. | 583-39-1 |
| EINECS NO. | 209 – 502 – 6 |
| FORMULA | C7H6N2S |
| MOL. WT. | 150.22 |
| INCHI | 1S/C7H6N2S/c10-7-8-5-3-1-2-4-6(5)9-7/h1-4H,(H2,8,9,10) |
| INCHIKEY | YHMYGUUIMTVXNW-UHFFFAOYSA-N |
| SMILES | SC1=NC2=CC=CC=C2N1 |
| SYNONYMS | Antioxidant Benzimidazole; Antioxidant MB; ASM MB; AOMB, 2-Benzimidazolethiol; O-Phenylene Thiourea; o -Phenylenethiourea; 1H-Benzimidazole-2-Thiol; 2-Benzimidazolinethione; 2-Thiobenzimidazole; Antiegene MB; 1,3-Dihydro-2H-Benzimidazole-2-Thione; USAF XF – 21; USAF EK – 6540; NCI – C60980; 2-Mercapto Benzimidazole, 2-Merkaptobenzimidazole, 2-Mercaptobenzoimidazole, Vulkanox MB, Nocrac MB |
| APPLICATIONS | Intermediate for manufacture of the anti-ulcer drug Lansoprazole (Lansoprasole) & Rabeprazole. |
| "NOTE: Finished Product manufactured at our factory under the current Manufacturing process (Route of Synthesis) does not contain any secondary amines which can form Nitrosamine. The potential for presence of nitrosamine impurity is minimized. - HOD (QA) - February 5, 2020." |
